|Articles|February 9, 2004
Innovation comes to wound products and therapies
The competition among dermal substitute manufacturers to meet the needsof a burgeoning population of chronic wound sufferers has resulted in agrowth market of continually improving products, according to Eliot N. Mostow,M.D., an Akron, Ohio, dermatologist and wound care specialist. The escalationof diabetes and diabetes-related wounds, along with an aging population,are just two factors influencing this trend, he said.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Global Hidradenitis Suppurativa Atlas (GHiSA) Finds HS Affects 1% of the World's Population
2
Delgocitinib Offers Targeted Relief for the Painful Burden of Chronic Hand Eczema
3
Top 5 Articles of the Week: December 7-12
4
Transformative Advances This Year and Beyond
5














